Related Experiment Video
Updated: Aug 12, 2026

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
Role of the 20-hydroxyl group in camptothecin binding by the topoisomerase I-DNA binary complex
1Department of Chemistry, University of Virginia, Charlottesville 22901, USA.
Abstract:
Recent findings concerning the structure of the covalent binary complex formed by DNA topisomerase I and its DNA substrate, as well as the nature of interactions with inhibitors that bind reversibly to this binary complex, have led to two proposed models for the binding of the prototype inhibitor camptothecin to the DNA-topisomerase I binary complex. While these models differ in many regards, they both suggest the involvement of the 20-OH group of camptothecin in a donor hydrogen bond with an enzyme side chain functional group. Presently, five analogues of camptothecin that differ only at C-20 have been evaluated for their ability to bind to the topoisomerase I-DNA binary complex and thereby inhibit enzyme function. Both 20-chloro- and 20-bromocamptothecin bound as well to the enzyme-DNA binary complex as 20-aminoCPT despite the absence of a substituent at C-20 capable of contributing a donor hydrogen bond.
Insights
Camptothecin analogues lacking a 20-OH group still effectively inhibit DNA topoisomerase I. This challenges existing models of inhibitor binding to the DNA-topoisomerase I complex, suggesting alternative interactions are involved.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- DNA topoisomerase I is a crucial enzyme in DNA replication and repair.
- Camptothecin is a known inhibitor of DNA topoisomerase I.
- Existing models propose the 20-OH group of camptothecin is essential for binding via hydrogen bonds.
Purpose of the Study:
- To evaluate camptothecin analogues with modifications at the C-20 position for their ability to inhibit DNA topoisomerase I.
- To investigate the role of the C-20 substituent in the binding of camptothecin to the DNA-topoisomerase I binary complex.
Main Methods:
- Synthesis of five camptothecin analogues differing only at the C-20 position.
- Assay of the binding affinity of these analogues to the DNA-topoisomerase I binary complex.
- Assessment of their enzyme inhibitory function.
Main Results:
- Analogues with 20-chloro and 20-bromo substituents bound effectively to the DNA-topoisomerase I binary complex.
- These halogenated analogues exhibited similar binding efficacy as 20-amino camptothecin.
- Inhibition of enzyme function was observed despite the absence of a hydrogen bond donor at C-20.
Conclusions:
- The 20-OH group of camptothecin is not essential for binding to the DNA-topoisomerase I binary complex.
- Alternative binding interactions, beyond donor hydrogen bonds involving the 20-OH group, likely contribute to inhibitor efficacy.
- These findings necessitate a revision of current models for camptothecin-DNA topoisomerase I interactions.
Related Concept Videos
DNA Helicases
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
DNA Damage can Stall the Cell Cycle
Drugs that Stabilize Microtubules
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Inhibitors of Bacterial DNA Synthesis

